Patents Assigned to IMPAX LABORATORIES, LLC
  • Patent number: 10098845
    Abstract: The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising levodopa and/or an ester of levodopa or salts thereof, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric coated polymer; and (b) a decarboxylase inhibitor component.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: October 16, 2018
    Assignee: IMPAX LABORATORIES, LLC
    Inventors: Ann Hsu, Liang C. Dong, Amy Ding, Suneel Gupta